Accessibility Menu

9 Meters Biopharma

(OTC) NMTRQ

Current Price$0.00
Market CapN/A
Since IPO (2018)-100%
5 Year-100%
1 Year-99%
1 Month+0%

9 Meters Biopharma Financials at a Glance

Market Cap

N/A

Revenue (TTM)

N/A

Net Income (TTM)

N/A

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

-87.47 (Low)

Price

$0.00

Volume

178

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

Estimated Earnings Date

May 29, 2026

NMTRQ News

GettyImages-943401146

Why 9 Meters Biopharma Stock Is Soaring Today

Prosper Junior BakinyApr 7, 2021
Getty-stock-market-data2

Why Blue Apron, Tribune Media, and Innovate Biopharmaceuticals Slumped Today

Steve SymingtonJul 16, 2018
Businessman looking at falling line chart

Why Innovate Biopharmaceuticals Stock Cratered Today

Keith SpeightsJul 16, 2018
Man behind stock chart

3 Biotech Stocks That Soared This Week: Are They Buys?

Keith SpeightsJun 30, 2018

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About 9 Meters Biopharma

Industry

Pharmaceuticals

Sector

Health Care

Employees

10

CEO

John Temperato

Website

9meters.com

Headquarters

Raleigh, NC 27612, US

NMTRQ Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

0%

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

N/A

Stock Overview

Market Cap

N/A

Shares Outstanding

14.46M

Volume

178

Avg. Volume

8.95K

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

9 Meters Biopharma Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
CurrentYOY CHG

Revenue

N/A

N/A

Gross Profit

N/A

N/A

Gross Margin

N/A

N/A

Market Cap

N/A

N/A

Market Cap/Employee

N/A

N/A

Employees

N/A

N/A

Net Income

N/A

N/A

EBITDA

N/A

N/A

Quarterly Fundamentals

Name
CurrentYOY CHG

Net Cash

N/A

N/A

Accounts Receivable

N/A

N/A

Inventory

N/A

N/A

Long Term Debt

N/A

N/A

Short Term Debt

N/A

N/A

Return on Assets

N/A

N/A

Return on Invested Capital

N/A

N/A

Free Cash Flow

N/A

N/A

Operating Cash Flow

N/A

N/A

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
CFRXQContraFect Corporation
$0.00+0.00%
IMVIFIMV Inc.
$0.00+0.00%
THMOThermoGenesis Holdings, Inc.
$0.00+0.00%
EFTReFFECTOR Therapeutics, Inc.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
STISolidion Technology
$22.71+3.51%
SQQQProShares Trust - ProShares UltraPro Short Qqq
$37.76+0.02%
TQQQProShares Trust - ProShares UltraPro Qqq
$85.22-0.02%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$14.64-0.02%

Questions About NMTRQ

What is the current price of 9 Meters Biopharma?

9 Meters Biopharma is trading at $0.00 per share.

What is the 52-week range for 9 Meters Biopharma?

Over the past 52 weeks, 9 Meters Biopharma has traded between $0.00 and $0.00.

How much debt does 9 Meters Biopharma have?

As of the most recent reporting period, 9 Meters Biopharma reported total debt of $19.73M.

How much cash does 9 Meters Biopharma have on hand?

9 Meters Biopharma reported $29.66M in cash and cash equivalents in its most recent financial results.

What is 9 Meters Biopharma’s dividend yield?

9 Meters Biopharma does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services